Eliquis

Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases
Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases
Fierce Pharma
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Flag link:
Bristol-Myers Squibb recalls mislabeled Eliquis medications
Bristol-Myers Squibb recalls mislabeled Eliquis medications
BioPharma Dive
Bristol-Myers Squibb
Eliquis
recalls
labeling
Flag link:
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
Fierce Pharma
Bristol-Myers Squibb
Pfizer
patents
Eliquis
patent lawsuits
generics
bloodthinners
Flag link:
Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin
Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin
BioPharma Dive
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Warfarin
Flag link:
Many at risk for stroke don’t get anti-clotting drugs
Many at risk for stroke don’t get anti-clotting drugs
Reuters
stroke
atrial fibrillation
Pradaxa
Xarelto
Eliquis
bloodthinners
Flag link:
Pfizer's 3 Fastest-Growing Drugs
Pfizer's 3 Fastest-Growing Drugs
Motley Fool
Pfizer
Ibrance
Eliquis
Xeljanz
Flag link:
Bristol-Myers Squibb Saw Improved Eliquis Sales in 3Q16
Bristol-Myers Squibb Saw Improved Eliquis Sales in 3Q16
Market Realist
Bristol-Myers Squibb
Eliquis
blood thinners
Flag link:
Eliquis Proving to Be a Major Growth Driver for Pfizer This Year
Eliquis Proving to Be a Major Growth Driver for Pfizer This Year
Market Realist
Eliquis
bloodthinners
Pfizer
Flag link:
Why Eliquis Matters to Bristol-Myers Squibb’s Cardiovascular Business
Why Eliquis Matters to Bristol-Myers Squibb’s Cardiovascular Business
Yahoo/Market Realist
Bristol-Myers Squibb
Eliquis
Flag link:
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
BMS expects fast-growing Eliquis to take the lead over Xarelto, Pradaxa
Fierce Pharma Marketing
bloodthinners
Bristol-Myers Squibb
Eliquis
Xarelto
Pradaxa
Bayer
Pfizer
JNJ
Boehringer Ingelheim
Flag link:
4 Blockbuster Drugs Whose Sales Could Easily Double
4 Blockbuster Drugs Whose Sales Could Easily Double
Motley Fool
Xtandi
Medivation
Astellas
Eliquis
Pfizer
Bristol-Myers Squibb
Revlimid
Celgene
Invokana
JNJ
Flag link:
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
Fierce Pharma
Pradaxa
Xarelto
Eliquis
bloodthinners
Warfarin
drug safety
JNJ
Boehringer Ingelheim
Pfizer
Bristol-Myers Squibb
Flag link:
J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
Fierce Pharma
JNJ
Bayer
Pfizer
Bristol-Myers Squibb
Eliquis
bloodthinners
Xarelto
Flag link:
Patient education 'useless' when it comes to Eliquis adherence: study
Patient education 'useless' when it comes to Eliquis adherence: study
Fierce Pharma
patient education
Eliquis
Bristol-Myers Squibb
Flag link:
Bayer, J&J touting Xarelto trial data to counteract Eliquis surge
Bayer, J&J touting Xarelto trial data to counteract Eliquis surge
Fierce Pharma Marketing
Bayer
JNJ
Xarelto
clinical trial data
bloodthinners
Eliquis
Pfizer
Bristol-Myers Squibb
Flag link:
Should Eliquis' surge make Xarelto fans very, very afraid? Not really, analyst says
Should Eliquis' surge make Xarelto fans very, very afraid? Not really, analyst says
Fierce Pharma Marketing
Eliquis
Xarelto
bloodthinners
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Flag link:
Bayer says Xarelto isn't losing U.S. market share to Eliquis
Bayer says Xarelto isn't losing U.S. market share to Eliquis
Yahoo/Reuters
Bayer
Xarelto
bloodthinners
Eliquis
Flag link:
Adexanet Alfa reverses anticoagulant effect of Eliquis in first stage of Phase 3
Adexanet Alfa reverses anticoagulant effect of Eliquis in first stage of Phase 3
Seeking Alpha
Eliquis
bloodthinners
Adexanet Alfa
Portola Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Flag link:
Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson
Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson
Motley Fool
JNJ
Eliquis
Bristol-Myers Squibb
Xarelto
bloodthinners
Flag link:
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod
Yahoo/Zacks
Bristol-Myers Squibb
Eliquis
deep vein thrombosis
pulmonary embolism
Flag link: